| Luna Family Hearing | |
|
925 Sw 4th Ave, Canby, OR 97013-3832 | |
| (503) 266-9668 | |
| (503) 266-9662 |
| Full Name | Luna Family Hearing |
|---|---|
| Type | Facility |
| Speciality | Audiologist-hearing Aid Fitter |
| Location | 925 Sw 4th Ave, Canby, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134528136 | NPI | - | NPPES |
| 500679840 | Medicaid | OR |
| Mailing Address | Practice Location Address |
|---|---|
| Luna Family Hearing Po Box 350, Maple Valley, WA 98038-0350 Ph: (425) 358-0956 | Luna Family Hearing 925 Sw 4th Ave, Canby, OR 97013-3832 Ph: (503) 266-9668 |
News Archive
A new opinion piece published online in the Annals of the American Thoracic Society provides an exhaustive examination of the ethics of using hospital resources on unvaccinated-by-choice COVID-19 pneumonia patients, versus patients with other serious illnesses whose diseases are not progressing as quickly.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, has filed a request with the U.S. Food and Drug Administration for designation of its lead product candidate, Neutrolin Catheter Lock Solution, as a qualified infectious disease product (QIDP) pursuant to the Generating Antibiotic Incentives Now (GAIN) title of the Food and Drug Administration Safety and Innovation Act.
Researchers at Karolinska Institutet in Sweden have identified 10 tumor-specific potential drug targets for the brain tumor glioblastoma. The results are presented in the scientific journal Cell Reports.
The Federation of State Medical Boards announced that it has recently been certified for a second time by the National Committee for Quality Assurance. The FSMB, which received its initial NCQA Certification in 2012, is certified under NCQA's Credentials Verification Organization Certification Program for the following credentials elements: Education and Training, Ongoing Monitoring of Sanctions, Medicare/Medicaid Sanctions, and Medical Board Sanctions.
The prevalence of diabetes in urban India is accelerating at a rapid rate and now stands at 5.5 percent (just under 20 million people), compared with 4.6 percent in 2007 - equivalent to a 30 percent increase in actual population numbers over the last four years - according to new research by GfK HealthCare's Roper Global Diabetes Group. Moreover, a full 10 percent of these patients have been diagnosed in the past 12 months.
› Verified 6 days ago